Operose Advisors’s Bio-Techne TECH Stock Holding History

Operose Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-337	Closed	-$22.9K	–	719
2023 Q3	$22.9K	Buy	+337	New	+$26.6K	0.01%	457

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Operose Advisors's TECH Position: Q4 2023 in Review

Operose Advisors sold out of Bio-Techne (TECH) in Q4 2023, closing a stake of 337 shares — an estimated $22.9K sold.

Operose Advisors first reported a position in TECH in Q3 2023 and held it in 1 quarter. The position peaked at $22.9K in Q3 2023. 530 funds tracked by Wall St. Rank hold TECH as of Q4 2023.

Operose Advisors reported no remaining Bio-Techne position as of Q4 2023 after selling out during the quarter.
Operose Advisors sold 337 Bio-Techne shares in Q4 2023, an estimated $22.9K.
Operose Advisors first reported a position in Bio-Techne in Q3 2023 and held it in 1 quarter.
Operose Advisors's Bio-Techne position peaked at $22.9K in Q3 2023.
530 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2023.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.